Clarus
- RxCUI
- 1299055
- RxNorm name
- Clarus
- Term type
- BN
- Status
- Active
- Updated
- 2026-07-20 06:54:28
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072012
- Active start
- 072012
- Multiple ingredient
- NO
- Branded
- YES
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| tolnaftate | 10637 |
Source Vocabulary Codes#
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D01AE | Other antifungals for topical use | ATC1-4 | tolnaftate | |
| MEDRT | D014047 | Tolnaftate | CHEM | has_ingredient | tolnaftate |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | tolnaftate |
| MEDRT | D014009 | Onychomycosis | DISEASE | ci_with | tolnaftate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | ci_with | tolnaftate |
| MEDRT | D014008 | Tinea Pedis | DISEASE | may_treat | tolnaftate |
| MEDRT | D014010 | Tinea Versicolor | DISEASE | may_treat | tolnaftate |
| MEDRT | N0000010265 | Squalene Monooxygenase Inhibitors | MOA | has_moa | tolnaftate |
| MEDRT | N0000008344 | Cellular Growth Phase Arrest | PE | has_pe | tolnaftate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | BN_CARDINALITY | single |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |